Tag: SID&GP

Russia and Bulgaria signed cooperation agreement

Shestakov and Stoimenova
Last week in Sofia Vladislav Shestakov, Director of the State Institute of Drugs and Good Practices, Deputy Head of the State GMP Inspectorate met with Assena Stoimenova, Executive Director of the Bulgarian Drug Agency.

Results of the 2nd All-Russian Inter-University GxP Summit

gxp-summit
The results of the 2nd All-Russian Inter-University GxP Summit with international participation “Selecting the Best: Time Forward” were summed up on July 6 in Sochi.

Conducting a joint training GMP-inspection

Тренинг
On June 4 and 5, 2018 employees of FSI “SID & GP”conducted a joint training GMP inspection with representatives of the regulatory entities of the Republic of Kazakhstan and the Kyrgyz Republic.

The Russian Federation is preparing data integrity guidance for pharma industry

phrama-data
The State Institute for Drugs and Good Practices (SID&GP), a federal budget-funded institution, and PQE Group are working together on elaborating an industry data integrity guidance.

SID & GP: many Russian pharma companies outdo their foreign counterparts

biocad
The inspections and checks conducted in major foreign pharmaceutical companies have a great importance for the development of Russian drug manufacturing industry.

Milan hosted a convention of the Russian-Italian subgroup for pharma industry

russia-italy
A delegation of the Russian Ministry of Industry and Trade lead by the Head of the Department of Pharmaceutical and Medical Industry Development – arrived in Italy with a mission to support cooperation between the countries.

SID & GP participated in “India Pharma 2018” conference

sid&gp
Last month the delegation of the Russian Federal State Institution “State Institute of Drugs and Good Practices” (FSI “SID & GP”) took part in the conference “India Pharma 2018”.

SID & GP is certified for conformity of the quality control system to ISO 9001:2015

sid&gp
Certificates for conformity of the quality management system accepted by FSI “SID & GP” to international standard requirements ISO 9001:2015 were handed out in a ceremony held on February 9, 2018.

SID & GP gave the explanation for the term “Additional materials”

sid&gp
In preparation of the initiative on the acceptance of additional materials after the inspection of a foreign drug manufacturer, SID & GP submitted an explanation of the term of “Additional materials”

SID&GP and Department of Drug Provision of Kyrgyzstan will cooperate

cooperation handshake
An official meeting between the State Institute of Drugs and Good Practices and the Department of Drug Provision of the Kyrgyz Republic was held on December 13

Contract pharmaceutical manufacturing sites in Russia are very relevant

contract manufacturing
A round table on Contract Manufacturing of Pharmaceutical Products was held on November 22, 2017, at Pharmtech & Ingredients 2017

NovaMedica receives a license for production site at its R&D center

novamedica
NovaMedica received a license from the FBI SID & GP for a pilot production site at its R&D center

Eurasian branch of ISPE was officially opened in Moscow

ispe
The official opening ceremony of ISPE Eurasian branch was held on October 17 during the Educational Conference organized by the State Institute for Drugs and Good Practices

SID & GP may conduct inspections for GxP compliance of EAEU from August 28

sid&gp
From August 28, the State Institute of Drugs and Good Practices is authorized to inspect Russian pharmaceutical manufacturers for compliance with all GxP standards.

SID&GP will create new educational modules together with American experts

sid & gp
In July, a delegation of the State Institute of Drugs and Good Practices, a federal budgetary institution, visited the United States

The localized pharmaceutical production in Russia reached 90 billion rubles

manufacturing
According to the Ministry of Industry and Trade, there are 566 production sites in Russia engaged in manufacturing of pharmaceutical products.